Fresenius Medical Care shares fall on weak US treatment volumes
BUZZ-Fresenius Medical Care shares fall on weak US treatment volumes ** German dialysis provider Fresenius Medical Care FMEG.DE drops as much as 8.8% in early Frankfurt trade, as investors focus on a second consecutive quarterly miss in U.S. patient volumes rather than a headline profit beat
** U.S. organic treatment growth fell 0.9% in the second quarter, worse than the 0.4% decline analysts had expected, and a deterioration from the first quarter's 0.4% drop, a local trader said
** "U.S. treatments disappoint again," the trader added, pointing to a miss in the metric most closely watched for signs of demand in Fresenius's largest market
** A temporary U.S. Medicare reimbursement boost, known as TDAPA, bolstered first-half profits but is expected to taper off in the second half of the year, the company has signalled
(Reporting by Maria Rugamer)
Recent news on Fresenius Medical Care AG
See all newsFMC seen down as Fresenius cuts stake to 20%
Germany's Fresenius cuts FMC stake to 20%
Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital
Brief: Fresenius Medical Care AG ABB Orders Below Eur 39.00 Per Share, Says Book Runner
Brief: Bookrunner Says Fresenius Medical ABB C. 13.4 Mln Shares, Books Are Closed